Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D Rebates, Tax On Patent Settlements May Be Added To Senate Finance Cmte. Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

Sen. Bill Nelson of Florida readying to offer major amendments that would significantly impact the drug industry in Committee markup.

You may also be interested in...



Comparative Effectiveness Amendment Left Out Of House Commerce Reform Markup, But Could Get Another Chance

Committee Chairman Waxman vows to work on measure proposed by Rep. Christensen - which would create public-private entity similar to proposal from Sen. Baucus - in time for House floor vote.

Comparative Effectiveness Amendment Left Out Of House Commerce Reform Markup, But Could Get Another Chance

Committee Chairman Waxman vows to work on measure proposed by Rep. Christensen - which would create public-private entity similar to proposal from Sen. Baucus - in time for House floor vote.

Health Reform Markup: Some Amendments Will Seek Higher Fees On Drug Firms

Senate Finance Committee will begin marking up its health reform bill Sept. 22.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS070011

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel